ArticlePharmacology research & perspectives2020

ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer.

Krishnarup Ghoshdastidar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.